Eric Murphy

Eric Murphy has a diverse work experience in the biopharmaceutical industry. Most recently, they are the CEO, CSO, and Co-Founder at Alterome Therapeutics, Inc, a position they have held since December 2021. Prior to that, they served as the CSO and Co-Founder at Kinnate Biopharma Inc. from 2018 to 2021. Eric was also a Board Member and Co-Founder at Fount Therapeutics LLC from 2017 to 2020. Earlier in their career, Eric held various positions at Crown Bioscience, Inc., Biosplice Therapeutics, Genomics Institute Of The Novartis Research Foundation (GNF), University of California, San Diego, and Kinagen, Inc. Eric started their career as a Postdoctoral Fellow at The Scripps Research Institute from 2003 to 2005. Throughout their career, Eric has demonstrated expertise in areas such as oncology research and development, drug discovery, and translational oncology.

Eric Murphy has a Bachelor of Science (B.S.) degree in Biochemistry from the University of California, Davis. Additionally, they hold a Doctor of Philosophy (Ph.D.) degree in Biology/Biological Sciences, General from UC Irvine. In terms of certifications, Eric obtained a certification named "Daniel Pink on Motivation" from LinkedIn in March 2021.